0
     

Report Added
Report already added
Thebaine Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Thebaine Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Thebaine market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Thebaine market segmented into
Extraction from Poppy Straw
Extraction from Opium

Based on the end-use, the global Thebaine market classified into
Oxycodone
Hydrocodone
Buprenorphine
Others

Based on geography, the global Thebaine market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Sun Pharmaceutical
Tasmanian Alkaloids
Alcaliber
TPI
Cepia-Sanofi
Taj Pharmaceuticals
Gansu Alkaloids
Market Breakdown by Regions
China
United States
Australia
Spain
France
Switzerland
United Kingdom
Rest of World
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL THEBAINE INDUSTRY
2.1 Summary about Thebaine Industry
2.2 Thebaine Market Trends
2.2.1 Thebaine Production & Consumption Trends
2.2.2 Thebaine Demand Structure Trends
2.3 Thebaine Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Extraction from Poppy Straw
4.2.2 Extraction from Opium
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Oxycodone
4.3.2 Hydrocodone
4.3.3 Buprenorphine
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Extraction from Poppy Straw
5.2.2 Extraction from Opium
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Oxycodone
5.3.2 Hydrocodone
5.3.3 Buprenorphine
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Extraction from Poppy Straw
6.2.2 Extraction from Opium
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Oxycodone
6.3.2 Hydrocodone
6.3.3 Buprenorphine
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Extraction from Poppy Straw
7.2.2 Extraction from Opium
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Oxycodone
7.3.2 Hydrocodone
7.3.3 Buprenorphine
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Extraction from Poppy Straw
8.2.2 Extraction from Opium
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Oxycodone
8.3.2 Hydrocodone
8.3.3 Buprenorphine
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Extraction from Poppy Straw
9.2.2 Extraction from Opium
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Oxycodone
9.3.2 Hydrocodone
9.3.3 Buprenorphine
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Sun Pharmaceutical
10.1.2 Tasmanian Alkaloids
10.1.3 Alcaliber
10.1.4 TPI
10.1.5 Cepia-Sanofi
10.1.6 Taj Pharmaceuticals
10.1.7 Gansu Alkaloids
10.1.8 Market Breakdown by Regions
10.1.9 China
10.1.10 United States
10.1.11 Australia
10.1.12 Spain
10.1.13 France
10.1.14 Switzerland
10.1.15 United Kingdom
10.1.16 Rest of World
10.2 Thebaine Sales Date of Major Players (2017-2020e)
10.2.1 Sun Pharmaceutical
10.2.2 Tasmanian Alkaloids
10.2.3 Alcaliber
10.2.4 TPI
10.2.5 Cepia-Sanofi
10.2.6 Taj Pharmaceuticals
10.2.7 Gansu Alkaloids
10.2.8 Market Breakdown by Regions
10.2.9 China
10.2.10 United States
10.2.11 Australia
10.2.12 Spain
10.2.13 France
10.2.14 Switzerland
10.2.15 United Kingdom
10.2.16 Rest of World
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Table
1.Table Thebaine Product Type Overview
2.Table Thebaine Product Type Market Share List
3.Table Thebaine Product Type of Major Players
4.Table Brief Introduction of Sun Pharmaceutical
5.Table Brief Introduction of Tasmanian Alkaloids
6.Table Brief Introduction of Alcaliber
7.Table Brief Introduction of TPI
8.Table Brief Introduction of Cepia-Sanofi
9.Table Brief Introduction of Taj Pharmaceuticals
10.Table Brief Introduction of Gansu Alkaloids
11.Table Brief Introduction of Market Breakdown by Regions
12.Table Brief Introduction of China
13.Table Brief Introduction of United States
14.Table Brief Introduction of Australia
15.Table Brief Introduction of Spain
16.Table Brief Introduction of France
17.Table Brief Introduction of Switzerland
18.Table Brief Introduction of United Kingdom
19.Table Brief Introduction of Rest of World
20.Table Products & Services of Sun Pharmaceutical
21.Table Products & Services of Tasmanian Alkaloids
22.Table Products & Services of Alcaliber
23.Table Products & Services of TPI
24.Table Products & Services of Cepia-Sanofi
25.Table Products & Services of Taj Pharmaceuticals
26.Table Products & Services of Gansu Alkaloids
27.Table Products & Services of Market Breakdown by Regions
28.Table Products & Services of China
29.Table Products & Services of United States
30.Table Products & Services of Australia
31.Table Products & Services of Spain
32.Table Products & Services of France
33.Table Products & Services of Switzerland
34.Table Products & Services of United Kingdom
35.Table Products & Services of Rest of World
36.Table Market Distribution of Major Players
37.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
38.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
39.Table Global Thebaine Market Forecast (Million USD) by Region 2021f-2026f
40.Table Global Thebaine Market Forecast (Million USD) Share by Region 2021f-2026f
41.Table Global Thebaine Market Forecast (Million USD) by Demand 2021f-2026f
42.Table Global Thebaine Market Forecast (Million USD) Share by Demand 2021f-2026f

Report Title: Thebaine Market Status and Trend Analysis 2017-2026 (COVID-19 Version)


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW